Concepedia

Anandkumar Raichurkar

AR

Statistics

Publications

21

Citations

983

H-Index

19

Active since

2012

Affiliations

AstraZeneca (India)(Current)

AstraZeneca (United Kingdom)

AstraZeneca (United States)

Medicines for Malaria Venture

GlaxoSmithKline (Spain)

Anandkumar Raichurkar is an author at AstraZeneca (India) specializing in drug discovery, pharmacology, and medicinal chemistry.

Publications per year

2012–2017

21

Publications

21

Discovery of Imidazo[1,2-<i>a</i>]pyridine Ethers and Squaramides as Selective and Potent Inhibitors of Mycobacterial Adenosine Triphosphate (ATP) Synthesis

Subramanyam J. Tantry, Shankar D. Markad, Vikas Shinde et al. · Journal of Medicinal Chemistry · 2017 · 126 citations

, , +17

Discovery of Pyrazolopyridones as a Novel Class of Noncovalent DprE1 Inhibitor with Potent Anti-Mycobacterial Activity

Manoranjan Panda, Sreekanth A. Ramachandran, Vasanthi Ramachandran et al. · Journal of Medicinal Chemistry · 2014 · 94 citations

, , +17

Aminopyrazinamides: Novel and Specific GyrB Inhibitors that Kill Replicating and Nonreplicating <i>Mycobacterium tuberculosis</i>

Pravin S. Shirude, Prashanti Madhavapeddi, Julie A. Tucker et al. · ACS Chemical Biology · 2012 · 88 citations

, , +17

Triaminopyrimidine is a fast-killing and long-acting antimalarial clinical candidate

Shahul Hameed P, Suresh Solapure, Vikas Patil et al. · Nature Communications · 2015 · 76 citations · Full text

, , +17

Thiazolopyridine Ureas as Novel Antitubercular Agents Acting through Inhibition of DNA Gyrase B

Manoj Kale, Anandkumar Raichurkar, Shahul Hameed P et al. · Journal of Medicinal Chemistry · 2013 · 66 citations · Full text

, , +15

1–5 of 21